Trial Profile
A Four-Arm, Parallel Design, Randomized, Double-Blinded, Placebo and Active Controlled Study for the Evaluation of the Effect of Maximum Therapeutic and Supratherapeutic Single-Dose ATX-101 on the QT/QTc Intervals in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2014
Price :
$35
*
At a glance
- Drugs Deoxycholic acid (Primary) ; Moxifloxacin
- Indications Subcutaneous fat disorders
- Focus Pharmacodynamics
- Sponsors Kythera Biopharmaceuticals
- 11 Jun 2014 New trial record